BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06365853-completion@plaintrial.com
DTSTAMP:20261028T011026Z
DTSTART;VALUE=DATE:202706
SUMMARY:A Study of Ocular Toxicity Evaluation and Mitigation During Treatme
 nt With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian C
 ancer With High Folate Receptor-Alpha Expression — estimated completion 
 date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06365853
URL:https://plaintrial.com/trial/NCT06365853
END:VEVENT
END:VCALENDAR